GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 72 filers reported holding GAMIDA CELL LTD in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $29,000 | +3.6% | 18,000 | 0.0% | 0.05% | +19.0% |
Q2 2022 | $28,000 | -62.7% | 18,000 | 0.0% | 0.04% | -45.5% |
Q1 2022 | $75,000 | +63.0% | 18,000 | 0.0% | 0.08% | +63.8% |
Q4 2021 | $46,000 | -35.2% | 18,000 | 0.0% | 0.05% | -30.9% |
Q3 2021 | $71,000 | -41.3% | 18,000 | +20.0% | 0.07% | -47.7% |
Q1 2021 | $121,000 | – | 15,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
Platform Technology Partners | 45,375 | $291,000 | 0.12% |
PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |